Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
154 hedge funds and large institutions have $1.44B invested in Silk Road Medical, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 78 increasing their positions, 26 reducing their positions, and 7 closing their positions.
414% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 7
200% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 26
117% more call options, than puts
Call options by funds: $4.99M | Put options by funds: $2.29M
44% more capital invested
Capital invested by funds: $999M → $1.44B (+$441M)
23% more funds holding
Funds holding: 125 → 154 (+29)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$41.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.8M |
| 3 |
BlackRock
New York
|
+$36M |
| 4 |
FAM
Fred Alger Management
New York
|
+$32.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Warburg Pincus
New York
|
-$186M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$23.3M |
| 3 |
DM
Deerfield Management
New York
|
-$23.2M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$9.91M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.86M |
SILK Hedge Fund Activity: Q2 2020 in Review
154 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2020, worth a combined $1.44B — up 44% from $999M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new SILK positions and 7 closed out — a net gain of 29 holders — while 78 added to existing stakes and 26 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $41.8M. The largest seller was Warburg Pincus, exiting entirely with an estimated $186M sold.
- 154 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2020, up from 125 in Q1 2020.
- Funds reported $1.44B of Silk Road Medical, Inc. Common Stock stock for Q2 2020, up 44% quarter-over-quarter.
- 36 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2020 and 7 closed out, a net change of +29 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2020 was Wasatch Advisors, an estimated $41.8M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q2 2020 was Warburg Pincus, an estimated $186M sold.
Based on aggregated 13F filings for Q2 2020.